Compare · TMO vs VICR
TMO vs VICR
Side-by-side comparison of Thermo Fisher Scientific Inc (TMO) and Vicor Corporation (VICR): market cap, price performance, sector, and recent activity on the wire.
Summary
- TMO operates in Industrials, while VICR operates in Technology - the two are in different parts of the market.
- TMO is the larger of the two at $257.53B, about 25.4x VICR ($10.14B).
- Both names hit the wire about 6 times in the past 4 weeks.
- TMO has more recent analyst coverage (25 ratings vs 13 for VICR).
- Company
- Thermo Fisher Scientific Inc
- Vicor Corporation
- Price
- $690.13-0.92%
- $191.51-12.81%
- Market cap
- $257.53B
- $10.14B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NYSE
- NASDAQ
- IPO
- News (4w)
- 6
- 6
- Recent ratings
- 25
- 13
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Vicor Corporation
Vicor Corporation, together with its subsidiaries, designs, develops, manufactures, and markets modular power components and power systems for converting electrical power in the United States, Europe, the Asia Pacific, and internationally. The company offers a range of brick-format DC-DC converters; complementary components; and input and output voltage, and output power products, as well as electrical and mechanical accessories. It also provides custom power systems solutions. The company serves independent manufacturers of electronic devices, original equipment manufacturers, and their contract manufacturers in the aerospace and aviation, defense electronics, industrial automation and equipment, instrumentation, test equipment, solid state lighting, telecommunications and networking infrastructure, and vehicles and transportation markets. Vicor Corporation was founded in 1981 and is headquartered in Andover, Massachusetts.
Latest TMO
- SEC Form 4 filed by Director Weisler Dion J
- SEC Form 4 filed by Director Sperling Scott M
- SEC Form 4 filed by Director Lynch Karen S
- SEC Form 4 filed by Director Johnson Jennifer M
- SEC Form 4 filed by Director Keith R. Alexandra
- Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 21, 2026
- Thermo Fisher Scientific Launches Gibco™ CHO-K1 Catalog Panel Media and Feed to Accelerate Biologics Development
- Thermo Fisher upgraded by UBS with a new price target
- CLSA initiated coverage on Thermo Fisher with a new price target
- Executive Vice President Shafer Michael D covered exercise/tax liability with 790 shares, decreasing direct ownership by 4% to 20,204 units (SEC Form 4)
Latest VICR
- USITC Institutes Investigation of Vertical Power Delivery (VPD) Modules and Computing Systems Infringing a Vicor Patent
- Vicor Corporation to Hold Third Quarter Earnings Conference Call and Webcast on October 20, 2026
- SEC Form 4 filed by Vicor Corporation
- SEC Form 4 filed by Vicor Corporation
- Chairman & CEO Vinciarelli Patrizio sold $6,322,515 worth of shares (20,000 units at $316.13) as part of a pre-agreed trading plan, decreasing direct ownership by 0.24% to 8,327,390 units (SEC Form 4)
- Vicor Corporation Raises Q3 2026 Revenue Guidance
- Vicor Corporation Raises Q3 2026 Revenue Guidance
- Vicor licenses VPD to a leading AI OEM
- Vicor acquires sites for additional ChiP fabs
- SEC Form 8-K filed by Vicor Corporation